Description

Estidol-D Tablets | Dienogest & Ethinylestradiol Tablets | Intra Life

Estidol-D Tablets by Intra Life are a combination hormonal prescription product containing Dienogest and Ethinylestradiol.

Dienogest is a progestogen, while ethinylestradiol is a synthetic estrogen. Combination products containing these hormones may be prescribed for specific gynaecological or contraceptive indications depending on the exact formulation and its approved indication.

Estidol-D is supplied in a 21-tablet blister format, making it suitable for prescribed cyclical dosing regimens where applicable.

Which Segment Does Estidol-D Belong To?

Primary Segment

Gynaecology & Women’s Health

Relevant Categories

* Hormonal therapy
* Combined hormonal preparations
* Oral hormonal tablets
* Gynaecology medicines
* Women’s healthcare
* Estrogen-progestogen combinations
* Reproductive health products

Target Professional Segment

Gynaecologists | Obstetricians | Women’s Health Clinics | Hospitals | Pharmacies | Gynaecology Product Distributors

Composition

Active Ingredients

Dienogest + Ethinylestradiol

For the website, enter the precise strength as:

Each tablet contains:
Dienogest – [verify strength]
Ethinylestradiol – [verify strength]

Do not add assumed strengths solely for SEO. Exact composition is particularly important for hormonal products because different strengths and formulations can have different approved indications and dosing instructions.

Indications / Uses

The exact approved indications for Estidol-D should be copied from its prescribing information.

Depending on the specific strength and regulatory approval, Dienogest + Ethinylestradiol combinations may be prescribed for purposes such as:

* Hormonal contraception
* Menstrual-cycle-related management
* Certain hormone-responsive gynaecological conditions
* Acne in selected patients when a combined hormonal contraceptive is otherwise appropriate, for formulations specifically approved for that use

Avoid stating that Estidol-D treats PCOS, endometriosis, infertility, heavy menstrual bleeding, acne or irregular periods unless that specific indication appears in Estidol-D’s approved prescribing information.

Mechanism of Action

How Dienogest + Ethinylestradiol Works

Step 1 – Estrogen Component

Ethinylestradiol is a synthetic estrogen that acts on estrogen receptors and contributes to suppression of the hypothalamic-pituitary-ovarian axis when used in an appropriate combined hormonal regimen.

Step 2 – Progestogenic Component

Dienogest acts as a progestogen through progesterone receptors.

Step 3 – Gonadotropin Suppression

In combined hormonal contraceptive regimens, estrogen and progestogen suppress gonadotropin secretion.

Step 4 – Ovulation Suppression

This hormonal effect can inhibit ovulation when the formulation is being used as an approved combined oral contraceptive.

Step 5 – Additional Contraceptive Effects

Progestogenic activity can also alter cervical mucus and the endometrium, contributing to contraceptive activity.

Packing

Brand: Estidol-D
Composition: Dienogest + Ethinylestradiol
Dosage Form: Tablets
Pack: 10 × 1 × 21 Tablets
Company: Intra Life
Segment: Gynaecology / Women’s Health

Dosage

Dosage: As directed by the physician/gynaecologist.

The pack contains 21 tablets per blister, but the exact dosing schedule should follow the approved Estidol-D prescribing information and the patient’s prescription.

Hormonal medicines should not be started, stopped, restarted or switched independently.

Usage Guide

For patient-facing website content, use a conservative guide:

1. Take Estidol-D exactly as prescribed by the doctor.
2. Follow the sequence and schedule indicated on the prescribed pack.
3. Take the tablet consistently according to the prescribed regimen.
4. Swallow with water.
5. Do not double doses unless specifically instructed for a missed tablet.
6. Follow the product leaflet’s instructions for missed tablets, vomiting/diarrhoea and interacting medicines.
7. Consult the prescriber before stopping or changing the treatment.

For contraceptive use, missed-tablet instructions can depend on how many tablets were missed and where the patient is in the cycle, so a generic “take two tablets” instruction should not be published.

Important Safety Information

Combined estrogen-progestogen products are not appropriate for everyone. Contraindications and precautions can include certain blood-clotting disorders, previous thromboembolic events, some cardiovascular conditions, migraine with aura, certain liver disorders and hormone-sensitive conditions, among others.

Smoking can further increase cardiovascular risk with combined hormonal contraceptives, particularly with increasing age.

The final product page should include the complete contraindications, warnings, drug interactions and adverse reactions from the approved Estidol-D prescribing information.

Frequently Asked Questions:

What is Estidol-D?

Estidol-D is an Intra Life prescription product containing Dienogest and Ethinylestradiol.

Which therapeutic segment does Estidol-D belong to?

Estidol-D belongs primarily to the gynaecology and women’s healthcare segment.

What is Dienogest?

Dienogest is a progestogen used in hormonal medicines.

What is Ethinylestradiol?

Ethinylestradiol is a synthetic estrogen used in several combined hormonal preparations.

How does Dienogest and Ethinylestradiol work?

In combined hormonal contraceptive formulations, the two hormones suppress the hypothalamic-pituitary-ovarian axis and ovulation, while progestogenic effects on cervical mucus and the endometrium also contribute to contraceptive activity.

How should Estidol-D be taken?

Estidol-D should be taken exactly according to the prescribing doctor’s instructions and the approved product information.

What is the Estidol-D pack size?

The displayed pack contains 10 × 1 × 21 tablets.
 

Keywords